Halitosis Treatment Market Analysis, Upcoming Trends, Emerging Growth, Key Players Segments and Forecast to 2023
Market Research Future
published a research report on Halitosis Treatment Market Research Report -
Global Forecast till 2023. Report gives a clear picture of current market
scenario which includes past and estimated future market size. The report
provides detail information and strategies of top key players in the industry.
The report also gives a broad study about different markets segments and
regions.
Halitosis Treatment Market Research Report is likely
to fuel the market growth of global halitosis treatment market at a CAGR of
18.58% during the forecast period 2018 to 2023
Leading Market Players
Colgate-Palmolive
Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar
Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S)
The halitosis treatment market is getting enough tailwind
from several quarters such as chronic & periodontal diseases, and
advancement in healthcare technologies. It is a clinical condition that results
in unpleasant odor from the mouth and significantly impacts the social life of
the patient. Psychological pressure can also trigger this disease. It can be
detected by using devices and test such as halimeter, gas chromatography, BANA
test, and Beta-galactosidase test. The global halitosis treatment market is
expected to reach a valuation of USD 22,153.4 billion by 2023 with a high CAGR
of 18.58% during the forecast period (2017-2023), discloses Market Research
Future (MRFR). The report further highlights factors such as the availability
of a wide range of dental healthcare product, and technological support, along
with government initiatives, as potential halitosis treatment market drivers.
Global Halitosis Treatment Market: Segmental Overview
Based on indication the market has been segmented
into liver, respiratory, gastrointestinal, kidney, systemic and others. The
liver segment is further sub-segmented into gall bladder diseases, liver
failure and others. The respiratory segment is further sub-segmented into
tuberculosis, pharyngitis, sinusitis, emphysema, pneumonia and others. The
gastrointestinal segment is further sub-segmented into stomach cancer,
pharyngitis, oesophageal reflux and malabsorption. The kidney segment also
covers Uremia. The systemic segment covers diabetes.
Based on type of halitosis the market has been
segmented into pathological halitosis and others. The pathological halitosis
segment covers extra oral pathological halitosis, and oral pathological
halitosis.
Based on drug treatment the market has been segmented
into ranitidine, antiseptic, antacids and other drugs.
Based on diagnostic test the market has been
segmented into gas chromatography, β-galactosidase activity assay, halimeter,
BANA test and other tests.
Regional Analysis:
The Americas accounted for a significant market share as the
region is witnessing a hike in gum diseases and extensive use of oral care
products such as toothpaste, mouthwashes, mouth sprays, etc.
Europe’s climb to the second spot can be attributed to the
growing awareness regarding halitosis and products available for its treatment.
The APAC region can expect rapid growth as factors such as rising cases of
chronic diseases, coupled with population boom are impacting the intake of
halitosis treatment. The MEA market can only expect
ACCESS THE COMPLETE REPORT @ https://www.marketresearchfuture.com/reports/halitosis-treatment-market-3758
Browse other
healthcare-related reports
About Market
Research Future:
MRFR team has
supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by
Components, Application, Logistics and market players for global, regional, and
country-level market segments, enable our clients to see more, know more, and
do more, which help to answer all their most important questions.
Contact:
Market Research
Future
+1 646 845 9312
Comments
Post a Comment